Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with Prednisolone — Donald J. Roohk (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with Prednisolone
Shared by
Marc Hellerstein
University of California, Berkeley
Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with Prednisolone
Article
2010
en
Authors
+8 more
DR
Donald J. Roohk
KV
Krista A Varady
ST
Scott Turner
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2003
<scp>l</scp>‐Carnitine: a nutritional modulator of glucocorticoid receptor functions
Salvatore Alesci
,
Massimo U. De Martino
,
Marco Mirani
,
Salvatore Benvenga
,
Francesco Trimarchi
,
Tomoshige Kino
,
George Chrousos
Article
1995
Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.
Jcw Mak
,
Masanori Nishikawa
,
Hideaki Shirasaki
,
Kikuo Miyayasu
,
Peter J Barnes
Article
2010
Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: Circadian rhythm-associated alterations of glucocorticoid actions in target tissues
Tomoshige Kino
,
George Chrousos
Article
2011
Peripheral CLOCK Regulates Target-Tissue Glucocorticoid Receptor Transcriptional Activity in a Circadian Fashion in Man
Evangelia Charmandari
,
George Chrousos
,
George Ι. Lambrou
,
Aikaterini N Pavlaki
,
Hisashi Koide
,
Sinnie Sin Man Ng
,
Tomoshige Kino
Article
2016
Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients
Amir Hakim
,
Younis Mohd Khan
,
Ignacio Esteban
,
Anna Miller‐Larsson
,
Peter J Barnes
,
Omar S. Usmani
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.